Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit

被引：0
|
作者：
Mascarella, Marco Antonio
Olonisakin, Tolani
Rumde, Purva
Vendra, Varun
Nance, Melonie
Kim, Seungwon
Kubik, Mark
Sridharan, Shaum
Ferris, Robert
Fenton, Moon
Clayburgh, Daniel
Ohr, James
Sen, Malabika
Joyce, Sonali
Herman, James
Grandis, Jennifer
Zandberg, Dan
Duvvuri, Umamaheswar
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4338
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4338
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Molecular targeted therapy: novel therapeutic approach for head and neck cancer
    Shrivastava, Swatantra
    Nagi, Ravleen
    Sharma, Saurabh
    Sanadi, Sajid Ahmed Rasul
    Dafallah, Elbadri Taha
    Ragit, Akshay
    THERAPEUTIC DELIVERY, 2020, 11 (10) : 637 - 651
  • [32] Progress of molecular targeted therapy for head and neck cancer in clinical aspects
    Kenji Nakano
    Molecular Biomedicine, 2
  • [33] The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer
    Spring, Laura M.
    Bar, Yael
    Isakoff, Steven J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 723 - 734
  • [34] Progress of molecular targeted therapy for head and neck cancer in clinical aspects
    Nakano, Kenji
    MOLECULAR BIOMEDICINE, 2021, 2 (01):
  • [35] Targeted therapy in head and neck cancer: Some success but more is expected !
    Sharma, Atul
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (03) : 4 - 4
  • [36] Targeted therapy for head and neck cancer: signaling pathways and clinical studies
    Qingfang Li
    Yan Tie
    Aqu Alu
    Xuelei Ma
    Huashan Shi
    Signal Transduction and Targeted Therapy, 8
  • [37] Targeted therapy for head and neck cancer: signaling pathways and clinical studies
    Li, Qingfang
    Tie, Yan
    Alu, Aqu
    Ma, Xuelei
    Shi, Huashan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [38] Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer:: the role of clinical response
    Pierga, JY
    Mouret, E
    Laurence, V
    Diéras, V
    Savigioni, A
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (08) : 1089 - 1096
  • [39] Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit
    Pandey, Durgatosh
    Pandey, Rambha
    Garg, Pankaj Kumar
    ANNALS OF SURGERY, 2017, 265 (04) : E41 - E42
  • [40] Targeted therapies in head and neck cancer
    Specenier, Pol M.
    Vermorken, Jan B.
    TARGETED ONCOLOGY, 2007, 2 (02) : 73 - 88
12345